Cargando…
Brain‐wide inferiority and equivalence tests in fMRI group analyses: Selected applications
Null hypothesis significance testing is the major statistical procedure in fMRI, but provides only a rather limited picture of the effects in a data set. When sample size and power is low relying only on strict significance testing may lead to a host of false negative findings. In contrast, with ver...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596945/ https://www.ncbi.nlm.nih.gov/pubmed/34529303 http://dx.doi.org/10.1002/hbm.25664 |
_version_ | 1784600502516842496 |
---|---|
author | Gerchen, Martin Fungisai Kirsch, Peter Feld, Gordon Benedikt |
author_facet | Gerchen, Martin Fungisai Kirsch, Peter Feld, Gordon Benedikt |
author_sort | Gerchen, Martin Fungisai |
collection | PubMed |
description | Null hypothesis significance testing is the major statistical procedure in fMRI, but provides only a rather limited picture of the effects in a data set. When sample size and power is low relying only on strict significance testing may lead to a host of false negative findings. In contrast, with very large data sets virtually every voxel might become significant. It is thus desirable to complement significance testing with procedures like inferiority and equivalence tests that allow to formally compare effect sizes within and between data sets and offer novel approaches to obtain insight into fMRI data. The major component of these tests are estimates of standardized effect sizes and their confidence intervals. Here, we show how Hedges' g, the bias corrected version of Cohen's d, and its confidence interval can be obtained from SPM t maps. We then demonstrate how these values can be used to evaluate whether nonsignificant effects are really statistically smaller than significant effects to obtain “regions of undecidability” within a data set, and to test for the replicability and lateralization of effects. This method allows the analysis of fMRI data beyond point estimates enabling researchers to take measurement uncertainty into account when interpreting their findings. |
format | Online Article Text |
id | pubmed-8596945 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85969452021-12-02 Brain‐wide inferiority and equivalence tests in fMRI group analyses: Selected applications Gerchen, Martin Fungisai Kirsch, Peter Feld, Gordon Benedikt Hum Brain Mapp Technical Report Null hypothesis significance testing is the major statistical procedure in fMRI, but provides only a rather limited picture of the effects in a data set. When sample size and power is low relying only on strict significance testing may lead to a host of false negative findings. In contrast, with very large data sets virtually every voxel might become significant. It is thus desirable to complement significance testing with procedures like inferiority and equivalence tests that allow to formally compare effect sizes within and between data sets and offer novel approaches to obtain insight into fMRI data. The major component of these tests are estimates of standardized effect sizes and their confidence intervals. Here, we show how Hedges' g, the bias corrected version of Cohen's d, and its confidence interval can be obtained from SPM t maps. We then demonstrate how these values can be used to evaluate whether nonsignificant effects are really statistically smaller than significant effects to obtain “regions of undecidability” within a data set, and to test for the replicability and lateralization of effects. This method allows the analysis of fMRI data beyond point estimates enabling researchers to take measurement uncertainty into account when interpreting their findings. John Wiley & Sons, Inc. 2021-09-16 /pmc/articles/PMC8596945/ /pubmed/34529303 http://dx.doi.org/10.1002/hbm.25664 Text en © 2021 The Authors. Human Brain Mapping published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Technical Report Gerchen, Martin Fungisai Kirsch, Peter Feld, Gordon Benedikt Brain‐wide inferiority and equivalence tests in fMRI group analyses: Selected applications |
title |
Brain‐wide inferiority and equivalence tests in fMRI group analyses: Selected applications |
title_full |
Brain‐wide inferiority and equivalence tests in fMRI group analyses: Selected applications |
title_fullStr |
Brain‐wide inferiority and equivalence tests in fMRI group analyses: Selected applications |
title_full_unstemmed |
Brain‐wide inferiority and equivalence tests in fMRI group analyses: Selected applications |
title_short |
Brain‐wide inferiority and equivalence tests in fMRI group analyses: Selected applications |
title_sort | brain‐wide inferiority and equivalence tests in fmri group analyses: selected applications |
topic | Technical Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596945/ https://www.ncbi.nlm.nih.gov/pubmed/34529303 http://dx.doi.org/10.1002/hbm.25664 |
work_keys_str_mv | AT gerchenmartinfungisai brainwideinferiorityandequivalencetestsinfmrigroupanalysesselectedapplications AT kirschpeter brainwideinferiorityandequivalencetestsinfmrigroupanalysesselectedapplications AT feldgordonbenedikt brainwideinferiorityandequivalencetestsinfmrigroupanalysesselectedapplications |